Skip to content

Minerals Technologies MTX Deferred Tax Asset Research And Development Capitalization

Deferred Tax Asset Research And Development Capitalization at other companies

Quantum Computing Inc. logo
Quantum Computing Inc.QUBT
$6.24M+144%
Corvex
 logo
Corvex MOVE
$5.16M-27.5%
Nuvation Bio logo
Nuvation BioNUVB
$78.79M-19.0%
PepsiCo logo
PepsiCoPEP
$134M-47.7%
Henry Schein logo
Henry ScheinHSIC
$10M-63.0%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$233.49M-27.8%

Other financials

Income statement

See full
Revenue$546.9M+11.2%
Gross profit$131.1M+9.6%
Operating income$58.7M+137%
Net income$36.2M+125%
EPS (diluted)$1.17+126%

Balance sheet

See full
Cash & equivalents$315.9M+3.0%
Total debt$960.0M-2.0%
Total equity$1.7B+8.1%
Total assets$3.5B+1.9%

Cash flow

See full
Operating cash flow$32.1M+830%
CapEx$23.1M+26.2%
Free cash flow$9.0M+140%

Valuation

See full
Market cap$2.44B+8.6%

Profitability

See full
Gross margin24.9%-0.7pp
Operating margin12.5%+10.0pp
Net margin-0.1%-7.3pp
FCF margin5.6%+1.5pp

Returns & leverage

See full
Return on equity-0.1%-9.4pp
Debt / equity0.6×-0.1×
Current ratio2.1×+0.2×

Where this comes from

Reported directly by Minerals Technologies in its filing.

Tagged under the XBRL concept mtx:DeferredTaxAssetResearchAndDevelopmentCapitalization.

The official record: Minerals Technologies’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Minerals Technologies's deferred tax asset research and development capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Minerals Technologies's deferred tax asset research and development capitalization?
Minerals Technologies (MTX) reported deferred tax asset research and development capitalization of $12.6M in Q4 2025.
What does deferred tax asset research and development capitalization mean?
This reflects the tax benefit arising from the capitalization and amortization of research and development expenditures for tax purposes. It indicates the future tax savings expected as these capitalized costs are deducted over time. This metric is useful for evaluating how tax policy changes regarding R&D treatment impact the company's future cash flows.